Randomized trial of valopicitabine (NM283), alone or with peginterferon, vs. retreatment with peginterferon plus ribavirin (PEGIFN/RBV) in hepatitis C patients with previous non-response to PEGIFN/RBV : first interim results

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1572261550119266944
  • NII Article ID
    10017328347
  • Data Source
    • CiNii Articles

Report a problem

Back to top